TR200101149T2 - Dış retina bozukluklarının tedavisi. - Google Patents
Dış retina bozukluklarının tedavisi.Info
- Publication number
- TR200101149T2 TR200101149T2 TR2001/01149T TR200101149T TR200101149T2 TR 200101149 T2 TR200101149 T2 TR 200101149T2 TR 2001/01149 T TR2001/01149 T TR 2001/01149T TR 200101149 T TR200101149 T TR 200101149T TR 200101149 T2 TR200101149 T2 TR 200101149T2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- retinal disorders
- external retinal
- external
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Dis retina bozukluklarinin, glutamat antagonistleriyle tedavi edilmesi için bilesimler ve bu bilesimlerin kullanilmasi açiklanmistir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10571298P | 1998-10-27 | 1998-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101149T2 true TR200101149T2 (tr) | 2001-10-22 |
Family
ID=22307389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01149T TR200101149T2 (tr) | 1998-10-27 | 1999-10-20 | Dış retina bozukluklarının tedavisi. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6509355B1 (tr) |
EP (1) | EP1126850A4 (tr) |
JP (1) | JP2002528416A (tr) |
KR (1) | KR20020002356A (tr) |
CN (1) | CN1324240A (tr) |
AR (1) | AR023687A1 (tr) |
AU (1) | AU761824B2 (tr) |
BR (1) | BR9914848A (tr) |
CA (1) | CA2347863C (tr) |
TR (1) | TR200101149T2 (tr) |
WO (1) | WO2000024396A1 (tr) |
ZA (1) | ZA200103236B (tr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009884A1 (en) * | 1997-06-30 | 2005-01-13 | Dreyer Evan B. | Calcium blockers to treat proliferative retinal diseases |
CA2295098A1 (en) * | 1997-06-30 | 1999-01-07 | Allergan Sales, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
JP2002182418A (ja) * | 2000-12-11 | 2002-06-26 | Konica Corp | 画像形成方法、画像形成装置 |
WO2002070478A1 (en) | 2001-03-06 | 2002-09-12 | Astrazeneca Ab | Indolone derivatives having vascular-damaging activity |
FR2822706A1 (fr) * | 2001-03-29 | 2002-10-04 | Univ Pasteur | Utilisation de composes organiques antagonistes de recepteurs pour le traitement de la degenerescence retinienne |
US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
US20050031652A1 (en) * | 2003-02-25 | 2005-02-10 | Allergan, Inc. | Compositions and methods comprising memantine and polyanionic polymers |
US20050283109A1 (en) * | 2003-03-07 | 2005-12-22 | Peyman Gholam A | Method and apparatus for lacrimal canal obstruction |
US7220224B1 (en) * | 2003-03-07 | 2007-05-22 | Minu, Llc | Retinal translocation and fixation using adhesive material |
US20050130878A1 (en) * | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Prevention of photic injury by administering a TACE inhibitor |
US20050277698A1 (en) * | 2004-01-05 | 2005-12-15 | Hughes Patrick M | Memantine delivery to the back of the eye |
US9693967B2 (en) * | 2005-09-07 | 2017-07-04 | Southwest Research Institute | Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates |
US7758778B2 (en) * | 2005-09-07 | 2010-07-20 | Southwest Research Institute | Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents |
US7261529B2 (en) * | 2005-09-07 | 2007-08-28 | Southwest Research Institute | Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents |
WO2008098027A2 (en) * | 2007-02-06 | 2008-08-14 | Allergan, Inc. | Treatment of ischemic retinal conditions with memantine |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534580A1 (fr) | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
FR2717080B1 (fr) * | 1994-03-09 | 1996-12-13 | Synthelabo | Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales. |
US5710165A (en) * | 1994-07-06 | 1998-01-20 | Synthelabo | Use of polyamine antagonists for the treatment of glaucoma |
US5604244A (en) * | 1995-06-07 | 1997-02-18 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing a polyamine antagonist |
CZ66598A3 (cs) | 1995-09-08 | 1998-06-17 | Synthelabo | Deriváty 4-(cykloalkyl)piperidinů a 4-(cykloalkylalkyl)-piperidinů, způsob jejich přípravy a léčivo, které je obsahuje |
FR2738567B1 (fr) | 1995-09-08 | 1997-10-17 | Synthelabo | Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique |
JP2000507205A (ja) * | 1996-01-02 | 2000-06-13 | シンテラボ | 眼の虚血障害の治療薬の製造のためのポリアミン部位拮抗物質の使用 |
CA2295098A1 (en) * | 1997-06-30 | 1999-01-07 | Allergan Sales, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
-
1999
- 1999-10-20 CN CN99812628A patent/CN1324240A/zh active Pending
- 1999-10-20 CA CA002347863A patent/CA2347863C/en not_active Expired - Fee Related
- 1999-10-20 EP EP99957471A patent/EP1126850A4/en not_active Ceased
- 1999-10-20 WO PCT/US1999/024502 patent/WO2000024396A1/en not_active Application Discontinuation
- 1999-10-20 BR BR9914848-0A patent/BR9914848A/pt not_active Application Discontinuation
- 1999-10-20 JP JP2000578006A patent/JP2002528416A/ja active Pending
- 1999-10-20 TR TR2001/01149T patent/TR200101149T2/tr unknown
- 1999-10-20 KR KR1020017005201A patent/KR20020002356A/ko not_active Application Discontinuation
- 1999-10-20 US US09/807,805 patent/US6509355B1/en not_active Expired - Lifetime
- 1999-10-20 AU AU15169/00A patent/AU761824B2/en not_active Ceased
- 1999-10-26 AR ARP990105400A patent/AR023687A1/es not_active Application Discontinuation
-
2001
- 2001-04-20 ZA ZA200103236A patent/ZA200103236B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1126850A4 (en) | 2003-01-15 |
BR9914848A (pt) | 2001-07-10 |
CA2347863A1 (en) | 2000-05-04 |
KR20020002356A (ko) | 2002-01-09 |
AU1516900A (en) | 2000-05-15 |
WO2000024396A1 (en) | 2000-05-04 |
JP2002528416A (ja) | 2002-09-03 |
EP1126850A1 (en) | 2001-08-29 |
US6509355B1 (en) | 2003-01-21 |
CN1324240A (zh) | 2001-11-28 |
ZA200103236B (en) | 2001-10-23 |
CA2347863C (en) | 2009-05-05 |
WO2000024396A9 (en) | 2000-09-28 |
AU761824B2 (en) | 2003-06-12 |
AR023687A1 (es) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE413192T1 (de) | Die vorbeugung und behandlung von netzhautischämie und ödem | |
IL144643A0 (en) | Jak-3 inhibitors for treating allergic disorders | |
TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
HK1051005A1 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
BR0309665A (pt) | Tratamento de deficiência de alfa-galactosidase a | |
ATE288747T1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
DE60219961T8 (de) | Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
TR200402628T4 (tr) | Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı | |
CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
DE69621799D1 (de) | Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen | |
DE69524623D1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
DK1000046T3 (da) | Piperazinderivater, der er aktive på den nedre urinvejskanal | |
DK0871446T3 (da) | Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve | |
DE60327335D1 (de) | Alpha 2b oder 2b/2c adrenozeptor-agonisten zur behandlung von morbus alzheimer und morbus parkinson | |
BR0015938A (pt) | Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa | |
PT1140080E (pt) | Utilizacao de riluzole no tratamento de traumatismos acusticos | |
DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
TR200101476T2 (tr) | N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması | |
DE69730515D1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlungen von stress störungen | |
BR0015424A (pt) | Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco | |
DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin | |
TR200000916T2 (tr) | İkameli piperidin türevleri. |